Company & Sponsor Intelligence
Northumbria University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed2
Countries1
Therapeutic footprint
adhdparkinsons
Indexed studies
NCT07281794Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease
parkinsons · United KingdomRECRUITING
parkinsons · United KingdomRECRUITING
NCT06051877Ocular Microtremor in Parkinson's Disease.
parkinsons · United KingdomUNKNOWN
parkinsons · United KingdomUNKNOWN
NCT06941779CuePD: Investigating the Effect of Personalised Auditory Cueing on Gait in Parkinson's Disease
parkinsons · United KingdomNA
parkinsons · United KingdomNA
NCT05476549Effects of Lemon Verbena Extract Supplementation in Sub-ADHD Children
adhd · United KingdomNA
adhd · United KingdomNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →